Michel Paquette

Quantitative myocardial perfusion and coronary reserve in rats with 13N-ammonia and small animal PET: impact of anesthesia and pharmacologic stress agents.

Psoralen photocrosslinking, a tool to study the chromatin structure of RNA polymerase I--transcribed ribosomal genes.

Repair-independent chromatin assembly onto active ribosomal genes in yeast after UV irradiation.

Complementary roles of yeast Rad4p and Rad34p in nucleotide excision repair of active and inactive rRNA gene chromatin.

[18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.

Quantitative hormone therapy follow-up in an ER+/ERαKD mouse tumor model using FDG and [11C]-methionine PET imaging.

Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.

Development of bifunctional chelates bearing hydroxamate arms for highly efficient (64)Cu radiolabeling.

BODIPY-17α-ethynylestradiol conjugates: Synthesis, fluorescence properties and receptor binding affinities.

Impact of dianionic and dicationic linkers on tumor uptake and biodistribution of [(64) Cu]Cu/NOTA peptide-based gastrin-releasing peptide receptors antagonists.

Improved Estrogen Receptor Assessment by PET Using the Novel RadiotracerF-4FMFES in Estrogen Receptor-Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial.

The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis.

Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer.

Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [Cu]-DOTHA-PEG-RM26.